Astera Labs, Inc. $ALAB Shares Acquired by Motley Fool Asset Management LLC

Key Points

• Motley Fool Asset Management increased its Astera Labs position by 41.7% in the third quarter, bringing its holdings to 15,830 shares valued at approximately $5.64 million. Institutional investors collectively own 60.47% of the company.
• Astera Labs reported strong quarterly results, with revenue rising 104.5% year over year to $392.4 million and EPS of $0.80, beating analysts’ $0.69 estimate. However, the stock’s elevated valuation— including a price-to-earnings ratio of 147.13—presents risk.
• Analyst sentiment is moderately positive, with a consensus rating of “Moderate Buy” and an average price target of $340.79, although several firms have downgraded the shares to “Hold.” Insiders sold more than $127 million of stock during the quarter, including sales by the COO and a director.

Motley Fool Asset Management LLC lifted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 41.7% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 15,830 shares of the company's stock after purchasing an additional 4,657 shares during the quarter. Motley Fool Asset Management LLC's holdings in Astera Labs were worth $5,635,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. BlackRock Inc. purchased a new position in Astera Labs in the second quarter valued at approximately $6,609,581,000. Atreides Management LP grew its stake in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock worth $368,890,000 after buying an additional 1,754,593 shares during the period. Van ECK Associates Corp grew its stake in Astera Labs by 20.0% during the second quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company's stock worth $1,080,980,000 after buying an additional 373,545 shares during the period. Bank of America Corp DE purchased a new stake in Astera Labs during the second quarter worth approximately $1,061,791,000. Finally, Amundi increased its position in shares of Astera Labs by 77.9% in the first quarter. Amundi now owns 1,880,830 shares of the company's stock worth $206,139,000 after acquiring an additional 823,477 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company's stock.

Astera Labs Stock Performance

Astera Labs stock opened at $297.20 on Thursday. The stock's 50 day moving average price is $308.72 and its 200 day moving average price is $253.91. The firm has a market capitalization of $51.56 billion, a PE ratio of 147.13 and a beta of 3.68. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same period in the prior year, the firm earned $0.44 earnings per share. The business's quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts forecast that Astera Labs, Inc. will post 2.71 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on ALAB. Barclays raised their target price on shares of Astera Labs from $200.00 to $325.00 and gave the company an "equal weight" rating in a research note on Monday, July 20th. Citigroup lowered shares of Astera Labs from a "buy" rating to a "hold" rating in a report on Friday, October 9th. Zacks Research cut shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Monday, October 5th. Needham & Company LLC increased their price target on Astera Labs from $260.00 to $425.00 and gave the company a "buy" rating in a report on Wednesday, August 5th. Finally, UBS Group reiterated a "neutral" rating and issued a $425.00 price target on shares of Astera Labs in a report on Wednesday, August 5th. Eleven equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company's stock. According to data from MarketBeat, Astera Labs presently has an average rating of "Moderate Buy" and a consensus target price of $340.79.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the firm's stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief operating officer owned 1,119,038 shares of the company's stock, valued at $380,864,583.30. This trade represents a 7.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the transaction, the director owned 253,863 shares of the company's stock, valued at approximately $71,114,642.19. The trade was a 41.89% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 408,558 shares of company stock worth $127,306,034. 10.40% of the stock is owned by company insiders.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Broad AI-chip rebound supports ALAB: Astera Labs advanced alongside a wider recovery in AI and semiconductor stocks, with improving sentiment toward the technology trade lifting demand for high-growth names. Astera Labs advances 10% amid broad AI chip rebound
• Positive Sentiment: Investors are looking beyond Nvidia: Market attention is broadening from Nvidia to suppliers and infrastructure companies that may benefit from continued AI data-center investment, putting Astera Labs’ connectivity products in focus. Astera Labs Stock Climbs as Investors Look Beyond Nvidia
• Positive Sentiment: Analyst sentiment remains supportive overall: Sell-side analysts have assigned the stock a “Moderate Buy” consensus, suggesting expectations for additional upside despite differing individual views. Astera Labs Stock Rated Moderate Buy by Sell-Side Analysts
• Neutral Sentiment: Strong fundamentals are balanced by valuation risk: A recent fund letter described Astera Labs’ core business as strong but identified the stock as a detractor, indicating that execution may be solid while the share price already reflects substantial growth expectations. Astera Labs Detracts Despite Strong Core Business
• Neutral Sentiment: Market backdrop is favorable but not company-specific: Strong results from other AI-related companies and Nvidia’s investment activity are reinforcing enthusiasm for the broader AI trade, though they do not directly change Astera Labs’ earnings outlook. 5 Things to Know Before the Stock Market Opens
• Negative Sentiment: Earnings-beat expectations are cautious: Zacks said Astera Labs lacks the combination of factors that typically signals a likely earnings beat, creating a potential near-term catalyst risk ahead of its report. Astera Labs Earnings Expected to Grow
• Negative Sentiment: Analyst views are mixed: Differing recommendations on Astera Labs highlight uncertainty over whether its rapid AI-driven growth can justify its elevated valuation. Analysts’ Opinions Are Mixed on Technology Stocks

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.